NextCompany

Compounding Pharmacy $6.1m EBITDA / $73m Gross Revenue - (Confidential)

Large-Scale Compounding Pharmacy with Strong EBITDA

On NextCompany since August 28, 2026 (today)

Location undisclosed
Financial summary
Asking price
N/A
Gross revenue
$73,000,000
Cash flow (SDE)
N/A
EBITDA
$6,100,000

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

The compounding pharmacy achieves $73,000,000 in gross revenue. It delivers $6,100,000 in EBITDA.

Who is a good fit for this business

  • Buyers active in the pharmaceutical or health sector.
  • Acquirers equipped to manage large inventory levels.
  • Firms pursuing high-EBITDA operations with substantial FF&E.

Details

Frequently Asked Questions

The compounding pharmacy reports $73,000,000 in gross revenue. EBITDA reaches $6,100,000.

Similar businesses